Blue Light Cystoscopy With Cysview® Registry

Part of paid clinical trials in Birmingham, Alabama.

Sponsor
Photocure
Study ID
NCT02660645
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

Registry study to gather more information on the current use of Blue Light Cystoscopy with Cysview (BLCC) in urologists' practices.

Key Dates

Start date
Apr 30, 2014
Status verified
Dec 2025
Primary completion
Dec 31, 2028
Completion
Dec 31, 2028

Study Design

Enrollment
4,400 participants (estimated)

Arms

  • Arm: Blue Light Cystoscopy with Cysview®
    Bladder cancer patients who have undergone Blue light cystoscopy with Hexaminolevulinate hydrochloride (Cysview®) 100mg in 50 milliliters (mL) reconstituted solution instilled intravesically into bladder prior to cystoscopy in operating room (OR). Retention time: 1-3 hours. The Karl Storz D-Light C Photodynamic Diagnostic (PDD) system is used for the cystoscopy procedure at the OR examination.

Primary Outcome Measure

Rate of detection of bladder malignancies [ Time Frame: 5 years ]

Central Contacts

Locations (23)

FacilityCityStateZIPSite coordinators
The University of Alabama at BirminghamBirminghamAlabama35294
Charles Peyton, MD
[email protected]
Charles Peyton, MD (PRINCIPAL_INVESTIGATOR)
Mayo ClinicPhoenixArizona85054
Mark Tyson, MD, MPH
[email protected]
Mark Tyson, MD, MPH (PRINCIPAL_INVESTIGATOR)
University of California Los AngelesLos AngelesCalifornia90095
Karim Chamie, MD
310-794-7700
Karim Chamie, MD (PRINCIPAL_INVESTIGATOR)
USC/Norris Comprehensive Cancer CenterLos AngelesCalifornia90033
Ileana Aldana
[email protected]
323-865-0702
Sia Daneshmand, MD (PRINCIPAL_INVESTIGATOR)
Anne Schuckman, MD (SUB_INVESTIGATOR)
Mihir Desai, MD (SUB_INVESTIGATOR)
Hooman Djaladat, MD (SUB_INVESTIGATOR)
Gerhard Fuchs, MD (SUB_INVESTIGATOR)
Virinder Bhardwaj, MD (SUB_INVESTIGATOR)
VA Palo Alto Health Care SystemPalo AltoCalifornia94304
Dorothy Trivedi
[email protected]
Joseph Liao, MD (PRINCIPAL_INVESTIGATOR)
James Crotty, MD (SUB_INVESTIGATOR)
John Leppert, MD (SUB_INVESTIGATOR)
John Lavelle, MD (SUB_INVESTIGATOR)
University of California, San FranciscoSan FranciscoCalifornia94143
Sima Porten, MD, MPH
[email protected]
415-885-3695
Sima Porten, MD, MPH (PRINCIPAL_INVESTIGATOR)
Sibley Memorial HospitalWashington D.C.District of Columbia20016
Armine Smith, MD
202-660-5561
Armine Smith, MD (PRINCIPAL_INVESTIGATOR)
Emory University School of MedicineAtlantaGeorgia30097
Vikram Narayan, MD
(404) 778-4898
Vikram Narayan, MD (PRINCIPAL_INVESTIGATOR)
Shreyas Joshi, MD (SUB_INVESTIGATOR)
Northwestern UniversityChicagoIllinois60611
Clay Arnett
Joshua Meeks, MD (PRINCIPAL_INVESTIGATOR)
Northshore University Health SystemEvanstonIllinois60201
Adam Vanderloo
Kristian Novakovic, MD (PRINCIPAL_INVESTIGATOR)
Indiana University School of MedicineIndianapolisIndiana46202
Lehman G Jennifer, RN, CCRP
[email protected]
Hristos Z Kaimakliotis, MD (PRINCIPAL_INVESTIGATOR)
University of Kansas Medical CenterKansas CityKansas66160
Jane Ledesma
[email protected]
913-588-8721
John Taylor, MD, MS (PRINCIPAL_INVESTIGATOR)
Jeffrey Holzbeierlein, MD, FACS (SUB_INVESTIGATOR)
Johns Hopkins MedicineBaltimoreMaryland21224
Morgan De Carli
[email protected]
Max Kates, MD (PRINCIPAL_INVESTIGATOR)
University of MinnesotaMinneapolisMinnesota55455
Maressa Twedt
[email protected]
612-626-6661
Hamed Ahmadi, MD (PRINCIPAL_INVESTIGATOR)
Subodh Regmi, MD (SUB_INVESTIGATOR)
NYU Langone's Perlmutter Cancer CenterNew YorkNew York10016
Gary Steinberg, MD
646-825-6300
Gary Steinberg, MD (PRINCIPAL_INVESTIGATOR)
Stony Brook UrologyStony BrookNew York11794-
Ohio State UniversityColumbusOhio43210
Rachel Link, CCRP
[email protected]
Kamal S Pohar, MD (PRINCIPAL_INVESTIGATOR)
Ohio State University Wexner Medical CenterColumbusOhio43210
Kamal Pohar, MD
[email protected]
Kamal Pohar, MD (PRINCIPAL_INVESTIGATOR)
Megan Merrill, DO (SUB_INVESTIGATOR)
Ahmad Shabsigh, MD (SUB_INVESTIGATOR)
David Sharp, MD (SUB_INVESTIGATOR)
Lexington Medical CenterWest ColumbiaSouth Carolina29169
Nicol Brandon
[email protected]
704-414-2870
T. Brian Willard, MD (PRINCIPAL_INVESTIGATOR)
David Lamb, MD (SUB_INVESTIGATOR)
Scott Sweazy, MD (SUB_INVESTIGATOR)
Keith Birghtbill, MD (SUB_INVESTIGATOR)
Michael Stotzer, MD (SUB_INVESTIGATOR)
UT SouthwesternDallasTexas75390
Yair Lotan, MD
214-645-8787
Yair Lotan, MD (PRINCIPAL_INVESTIGATOR)
Aditya Bagrodia, MD (SUB_INVESTIGATOR)
Michael E. DeBakey VA Medical CenterHoustonTexas77030
Ashley Jones, BS, CCRP
[email protected]
713-791-1414
Jennifer Taylor, MD, MPH (PRINCIPAL_INVESTIGATOR)
Jeffrey Jones, MD (SUB_INVESTIGATOR)
Sidney Worsham, MD (SUB_INVESTIGATOR)
University of Washington MedicineSeattleWashington98195
John Gore, MD
(206) 598-4294
John Gore, MD (PRINCIPAL_INVESTIGATOR)
Charleston Area Medical CenterCharlestonWest Virginia25301-

Find similar trials in Birmingham, AL

By condition
Bladder cancer
By specialty
OncologyUrology
By research site
The University of Alabama at Birmingham· Birmingham, ALMayo Clinic· Phoenix, AZUniversity of California Los Angeles· Los Angeles, CAUSC/Norris Comprehensive Cancer Center· Los Angeles, CAVA Palo Alto Health Care System· Palo Alto, CAUniversity of California, San Francisco· San Francisco, CA

Related Studies